Evidence map›Paper›PMID 38978111›Full record

ArticleCritical care (London, England)2024

Clinical application of targeted next-generation sequencing in severe pneumonia: a retrospective review.

Peng Zhang, Baoyi Liu, Shuang Zhang, Xuefei Chang, Lihe Zhang, Dejian Gu, Xin Zheng, Jiaqing Chen, Saiyin Xiao, Zhentao Wu and 15 more

Abstract read
In one paragraph

Article in Critical care (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed.

  1. Rapid diagnosis ofExperimental and therapeutic medicine · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Association between normalizedTranslational pediatrics · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. A Pilot Study ofDiagnostics (Basel, Switzerland) · 2026
    Article
  14. Review
  15. Article
  16. Review
  17. Frontiers in medicine · 2026
    Article
  18. Article
  19. Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Peng Zhang *Department of Critical Care Medicine, Jiangmen Central Hospital, Jiangmen, 529030, China.
Baoyi Liu *Clinical Experimental Center, Jiangmen Engineering Technology Research Center of Clinical Biobank and Translational Research, Jiangmen Central Hospital, Jiangmen, 529030, China.
Shuang Zhang *Department of Critical Care Medicine, Jiangmen Central Hospital, Jiangmen, 529030, China.
Xuefei ChangDepartment of Respiratory and Critical Care Medicine, Jiangmen Central Hospital, Jiangmen, 529030, China.
Lihe ZhangDepartment of Respiratory and Critical Care Medicine, Jiangmen Central Hospital, Jiangmen, 529030, China.
Dejian GuGeneplus-Beijing Institute, Beijing, 102206, China.
Xin ZhengGeneplus-Beijing Institute, Beijing, 102206, China.
Jiaqing ChenClinical Experimental Center, Jiangmen Engineering Technology Research Center of Clinical Biobank and Translational Research, Jiangmen Central Hospital, Jiangmen, 529030, China.
Saiyin XiaoDepartment of Critical Care Medicine, Jiangmen Central Hospital, Jiangmen, 529030, China.
Zhentao WuDepartment of Critical Care Medicine, Jiangmen Central Hospital, Jiangmen, 529030, China.
Xuemin CaiDepartment of Critical Care Medicine, Jiangmen Central Hospital, Jiangmen, 529030, China.
Mingfa LongDepartment of Critical Care Medicine, Jiangmen Central Hospital, Jiangmen, 529030, China.
Wenjie LuClinical Experimental Center, Jiangmen Engineering Technology Research Center of Clinical Biobank and Translational Research, Jiangmen Central Hospital, Jiangmen, 529030, China.
Mingzhu ZhengClinical Experimental Center, Jiangmen Engineering Technology Research Center of Clinical Biobank and Translational Research, Jiangmen Central Hospital, Jiangmen, 529030, China.
Rongrong ChenGeneplus-Beijing Institute, Beijing, 102206, China.
Rui GaoGeneplus-Beijing Institute, Beijing, 102206, China.
Yan ZhengDepartment of Research and Development, Guangdong Research Institute of Genetic Diagnostic and Engineering Technologies for Thalassemia, Hybribio Limited, Guangzhou, 510000, China.
Jinhua WuDepartment of Clinical Laboratory, Jiangmen Central Hospital, Jiangmen, 529030, China.
Qiujuan FengDepartment of Clinical Laboratory, Jiangmen Central Hospital, Jiangmen, 529030, China.
Gang HeDepartment of Infectious Diseases, Jiangmen Central Hospital, Jiangmen, 529030, China.
Yantang ChenDepartment of Critical Care Medicine, Jiangmen Central Hospital, Jiangmen, 529030, China.
Weihao ZhengDepartment of Critical Care Medicine, Jiangmen Central Hospital, Jiangmen, 529030, China.
Wanli ZuoClinical Experimental Center, Jiangmen Engineering Technology Research Center of Clinical Biobank and Translational Research, Jiangmen Central Hospital, Jiangmen, 529030, China. zuowanli@jmszxyy.com.cn.
Yanming HuangClinical Experimental Center, Jiangmen Engineering Technology Research Center of Clinical Biobank and Translational Research, Jiangmen Central Hospital, Jiangmen, 529030, China. huangyanming_jxy@163.com.
Xin ZhangClinical Experimental Center, Jiangmen Engineering Technology Research Center of Clinical Biobank and Translational Research, Jiangmen Central Hospital, Jiangmen, 529030, China. zhangx45@mail3.sysu.edu.cn.

Funding

China Postdoctoral Science Foundation Grant 2019M660206National Natural Science Foundation of China 82273384Science and Technology Project of Guangdong Province 2020A1515011421Science and Technology Project of Guangdong Province 2021A1515220180The Jiangmen Basic and Applied Basic Research Key Programs JZ202202
6 · The paper itself

Abstract

backgroundThe precise identification of the underlying causes of infectious diseases, such as severe pneumonia, is essential, and the development of next-generation sequencing (NGS) has enhanced the effectiveness of pathogen detection. However, there is limited information on the systematic assessment of the clinical use of targeted next-generation sequencing (tNGS) in cases of severe pneumonia.

methodsA retrospective analysis was conducted on 130 patients with severe pneumonia treated in the ICU from June 2022 to June 2023. The consistency of the results of tNGS, metagenomics next-generation sequencing (mNGS), and culture with the clinical diagnosis was evaluated. Additionally, the results for pathogens detected by tNGS were compared with those of culture, mNGS, and quantitative reverse transcription PCR (RT-qPCR). To evaluate the efficacy of monitoring severe pneumonia, five patients with complicated infections were selected for tNGS microbiological surveillance. The tNGS and culture drug sensitisation results were then compared.

resultsThe tNGS results for the analysis of the 130 patients showed a concordance rate of over 70% with clinical diagnostic results. The detection of pathogenic microorganisms using tNGS was in agreement with the results of culture, mNGS, and RT-qPCR. Furthermore, the tNGS results for pathogens in the five patients monitored for complicated infections of severe pneumonia were consistent with the culture and imaging test results during treatment. The tNGS drug resistance results were in line with the drug sensitivity results in approximately 65% of the cases.

conclusionsThe application of tNGS highlights its promise and significance in assessing the effectiveness of clinical interventions and providing guidance for anti-infection therapies for severe pneumonia.

Indexed as

High-Throughput Nucleotide SequencingPneumoniaAgedFemaleHumansIntensive Care UnitsMaleMiddle AgedRetrospective StudiesCultureMetagenomics next-generation sequencingSevere pneumoniaTargeted next-generation sequencing

Identifiers

PMID38978111
PMCPMC11232260

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.